Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209–49. https://doi.org/10.3322/caac.21660
Article CAS PubMed Google Scholar
Zhang X, El-Serag HB, Thrift AP (2021) Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare. Cancer Causes Control 32(4):317–25. https://doi.org/10.1007/s10552-020-01386-x
Giannini EG, Cucchetti A, Erroi V, Garuti F, Odaldi F, Trevisani F (2013) Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it? World J Gastroenterol 19(47):8808–21. https://doi.org/10.3748/wjg.v19.i47.8808
Article PubMed PubMed Central Google Scholar
Zhou H, Song T (2021) Conversion therapy and maintenance therapy for primary hepatocellular carcinoma. Biosci Trends 15(3):155–60. https://doi.org/10.5582/bst.2021.01091
Article CAS PubMed Google Scholar
Viganò L, Procopio F, Mimmo A, Donadon M, Terrone A, Cimino M, et al (2018) Oncologic superiority of anatomic resection of hepatocellular carcinoma by ultrasound-guided compression of the portal tributaries compared with nonanatomic resection: An analysis of patients matched for tumor characteristics and liver function. Surgery 164(5):1006–13. https://doi.org/10.1016/j.surg.2018.06.030
Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA, et al (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243(2):229–35. https://doi.org/10.1097/01.sla.0000197706.21803.a1
Article PubMed PubMed Central Google Scholar
Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S (2015) Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg 261(5):947–55. https://doi.org/10.1097/sla.0000000000000710
Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, et al (2009) Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study. Eur J Surg Oncol 35(2):174–9. https://doi.org/10.1016/j.ejso.2008.01.027
Article CAS PubMed Google Scholar
Xing H, Sun LY, Yan WT, Quan B, Liang L, Li C, et al (2021) Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis. Surgery 169(4):911–20. https://doi.org/10.1016/j.surg.2019.11.005
Karakaya E, Akdur A, Ayvazoğlu Soy E, Moray G, Boyvat F, Haberal M (2022) Treatment of Posttransplant Hepatocellular Carcinoma Recurrence. Exp Clin Transplant 20(1):59–61. https://doi.org/10.6002/ect.2021.0450
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, et al (2023) Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial. Lancet 402(10415):1835–47. https://doi.org/10.1016/s0140-6736(23)01796-8
Article CAS PubMed Google Scholar
Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, et al (2010) Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol 45(3):133–41. https://doi.org/10.1097/RLI.0b013e3181caea5b
Reimer P, Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, Tombach B, et al (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199(1):177–83. https://doi.org/10.1148/radiology.199.1.8633143
Article CAS PubMed Google Scholar
Davenport MS, Viglianti BL, Al-Hawary MM, Caoili EM, Kaza RK, Liu PS, et al (2013) Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology 266(2):452–61. https://doi.org/10.1148/radiol.12120826
Min JH, Kim JM, Kim YK, Kang TW, Lee SJ, Choi GS, et al (2018) Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System. Hepatology 68(6):2254–66. https://doi.org/10.1002/hep.30122
Article CAS PubMed Google Scholar
Zhang K, Xie SS, Li WC, Ye ZX, Shen ZW, Shen W (2022) Prediction of microvascular invasion in HCC by a scoring model combining Gd-EOB-DTPA MRI and biochemical indicators. Eur Radiol 32(6):4186–97. https://doi.org/10.1007/s00330-021-08502-8
Article CAS PubMed Google Scholar
Chan AWH, Zhong J, Berhane S, Toyoda H, Cucchetti A, Shi K, et al (2018) Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. J Hepatol 69(6):1284–93. https://doi.org/10.1016/j.jhep.2018.08.027
Ali MM, Ahmed K, Bui FM, Paul BK, Ibrahim SM, Quinn JMW, et al (2021) Machine learning-based statistical analysis for early stage detection of cervical cancer. Comput Biol Med 139:104985. https://doi.org/10.1016/j.compbiomed.2021.104985
Zhang M, Tong E, Hamrick F, Lee EH, Tam LT, Pendleton C, et al (2021) Machine-Learning Approach to Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors: A Multicenter Study. Neurosurgery 89(3):509–17. https://doi.org/10.1093/neuros/nyab212
Article PubMed PubMed Central Google Scholar
Heo J, Yoon JG, Park H, Kim YD, Nam HS, Heo JH (2019) Machine Learning-Based Model for Prediction of Outcomes in Acute Stroke. Stroke 50(5):1263–5. https://doi.org/10.1161/strokeaha.118.024293
Han JW, Lee SK, Kwon JH, Nam SW, Yang H, Bae SH, et al (2024) A Machine Learning Algorithm Facilitates Prognosis Prediction and Treatment Selection for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma. Clin Cancer Res 30(13):2812–21. https://doi.org/10.1158/1078-0432.Ccr-23-3978
Article CAS PubMed Google Scholar
He Y, Luo L, Shan R, Qian J, Cui L, Wu Z, et al (2023) Development and Validation of a Nomogram for Predicting Postoperative Early Relapse and Survival in Hepatocellular Carcinoma. J Natl Compr Canc Netw 22(1d):e237069. https://doi.org/10.6004/jnccn.2023.7069
Costa AF, Thipphavong S, Arnason T, Stueck AE, Clarke SE (2018) Fat-Containing Liver Lesions on Imaging: Detection and Differential Diagnosis. AJR Am J Roentgenol 210(1):68–77. https://doi.org/10.2214/ajr.17.18136
Kang HJ, Kim H, Lee DH, Hur BY, Hwang YJ, Suh KS, et al (2021) Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery. Radiology 300(3):572–82. https://doi.org/10.1148/radiol.2021204352
Renzulli M, Brocchi S, Cucchetti A, Mazzotti F, Mosconi C, Sportoletti C, et al (2016) Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma? Radiology 279(2):432–42. https://doi.org/10.1148/radiol.2015150998
Kim KA, Kim MJ, Jeon HM, Kim KS, Choi JS, Ahn SH, et al (2012) Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 35(3):629–34. https://doi.org/10.1002/jmri.22876
(2018) EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 69(1):182–236. https://doi.org/10.1016/j.jhep.2018.03.019
Sperandei S (2014) Understanding logistic regression analysis. Biochemia Medica 24(1):12–8. https://doi.org/10.11613/bm.2014.003
Article PubMed PubMed Central Google Scholar
Bertsimas D, Dunn J (2017) Optimal classification trees. Machine Learning 106(7):1039–82. https://doi.org/10.1007/s10994-017-5633-9
Breiman L (2001) Random Forests. Machine Learning 45(1):5–32. https://doi.org/10.1023/A:1010933404324
Friedman JH (2001) Greedy Function Approximation: A Gradient Boosting Machine. The Annals of Statistics 29(5):1189–232.
Comments (0)